CVE-2008-4168
Cross-site scripting (XSS) vulnerability in verify_login.jsp in Pro2col Stingray FTS allows...
Cross-site scripting (XSS) vulnerability in verify_login.jsp in Pro2col Stingray FTS allows remote attackers to inject arbitrary web script or HTML via the form_username parameter (aka user name field).
Exploit likelihood
What each source reports
NVD Score used
Cross-site scripting (XSS) vulnerability in verify_login.jsp in Pro2col Stingray FTS allows remote attackers to inject arbitrary web script or HTML via the form_username parameter (aka user name field).
- Record
CVE-2008-4168- CVSS 2.0
- 4.3 Medium
AV:N/AC:M/Au:N/C:N/I:P/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
CVE List No score
Cross-site scripting (XSS) vulnerability in verify_login.jsp in Pro2col Stingray FTS allows remote attackers to inject arbitrary web script or HTML via the form_username parameter (aka user name field).
- Record
CVE-2008-4168- Updated
- 2026-11-02
EUVDEUVD-2008-4151 No score
Cross-site scripting (XSS) vulnerability in verify_login.jsp in Pro2col Stingray FTS allows remote attackers to inject arbitrary web script or HTML via the form_username parameter (aka user name field).
- Record
EUVD-2008-4151- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-g472-458r-vx2g No score
Cross-site scripting (XSS) vulnerability in verify_login.jsp in Pro2col Stingray FTS allows...
Cross-site scripting (XSS) vulnerability in verify_login.jsp in Pro2col Stingray FTS allows remote attackers to inject arbitrary web script or HTML via the form_username parameter (aka user name field).
- Record
GHSA-g472-458r-vx2g- Weakness
- CWE-79
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2008-4168 is a medium vulnerability (CVSS 4.3) in Pro2col Stingray Fts, published September 22, 2008. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.06%, the 64th percentile. No source names a fixed version.